Blog - Page 1290 of 5718

TuesdayJul 27, 2021 9:58 am

QualityStocksNewsBreaks – Green Hygienics Holdings Inc. (GRYN) Names New Senior VP of Global Sales and Business Development

Green Hygienics (OTCQB: GRYN) has appointed a new senior vice president. David Racz, a seasoned pharmaceutical executive, has been named senior VP of global sales and business development for the innovative, tech-driven company. Racz has garnered extensive experience in the both the pharma and cannabis sectors, having served in global, senior-level positions with well-known pharmaceutical companies including Pfizer, GlaxoSmithKline and Novartis. At Pfizer, he was vice president of sales and human resources, overseeing the largest expansion in Pfizer’s sales force in history. At SmithKline Beecham, he managed more than 4,000 sales, marketing and R&D employees, who were located in 20 countries…

TuesdayJul 27, 2021 9:53 am

QualityStocksNewsBreaks – Grapefruit USA Inc. (GPFT) Shares Insta Message from ELove: ‘Best Thing on the Market’

Grapefruit USA (OTCQB: GPFT), a premiere California-based cannabis and hemp company, and its flagship product, Hourglass THC+CBD Patchless Patch Topical Cream, has received an Instagram endorsement from Grammy Award-winning writer, producer and director Damien Matthias, known as ELove. ELove has performed and co-produced with LL Cool J, one of Def Jams Records’ first artists. He also played a key role in launching the careers of Tupac Shakur and John Forte of the Fugees and was integrally involved in the pre-internet marketing team of Def Jam Records, one of the most successful independent labels of all time. “Hourglass, the best thing…

TuesdayJul 27, 2021 9:30 am

Flora Growth Corp. (NASDAQ: FLGC) Is ‘One to Watch’

Flora Growth is uniquely positioned to achieve revenue growth, with a balance sheet supported by two successful financings and the recent launch of multiple operating divisions The company boasts a robust M&A pipeline featuring strategic targets with near-term revenue growth opportunities and global distribution channels Flora Growth is led by an exceptional management team featuring cannabis, CPG, and capital markets experts who have raised more than $3 billion in combined public financings The company’s brand portfolio features 280+ products, 70+ medical and cosmetic licenses, and 2,500+ points of distribution across Latin America and the U.S. Flora Growth has a healthy…

TuesdayJul 27, 2021 9:30 am

The Alkaline Water Company Inc. (NASDAQ: WTER) (CSE: WTER) Finalizes Distribution Agreement with Largest Food Retailer in the Mid-Atlantic

WTER’s distribution agreement calls for Giant Food to carry select WTER Alkaline88(R) and A88 Infused(R) offerings The distributor will offer WTER beverages in all 164 locations. Giant Food serves market of 60 million people with over $5 billion in sales. In an move illustrative of its continued commitment to expansion and growth, The Alkaline Water Company (NASDAQ: WTER) (CSE: WTER) announced that it has partnered with Giant Food, the largest food retailer in the Mid-Atlantic region. The distribution agreement calls for Giant Food to carry select WTER Alkaline88 and A88 Infused offerings in all locations. “This is our biggest win to date…

TuesdayJul 27, 2021 9:00 am

Lexaria Bioscience Corp. (NASDAQ: LEXX) Completes VIRAL-A20-3 Pharmacokinetic Study on DehydraTECH(TM) Enabled Colchicine

The study indicated enhanced delivery of colchicine using the company’s proprietary DehydraTECH(TM) technology Lexaria collaborates with the National Research Council (“NRC”), Canada’s leading research and technology organization The company has 20 patents granted and over 50 pending patents in over 40 countries around the world The global market for advanced drug delivery systems was valued at $231 billion in 2020 and is expected to grow to $310 billion by 2025 Lexaria Bioscience (NASDAQ: LEXX), a global innovator in drug delivery platforms, recently announced that the tolerability and pharmacokinetic study entitled VIRAL-A20-3 was completed and yielded positive results. The study demonstrated…

TuesdayJul 27, 2021 9:00 am

Save Foods Inc. (NASDAQ: SVFD) Receives Seventh Global Patent for Proprietary Composition Method

Israeli Patent Office grants patent for new-generation, natural, disinfecting composition and method to protect edible matter from decay Patent is further validation of SVFD’s technology, an important step in building company’s IP portfolio Food waste is a social, humanitarian, economic and environment concern Save Foods (NASDAQ: SVFD), an agri-food tech company focused on creating solutions to food waste and loss as well as food safety, has been granted its seventh global patent, protecting the company’s innovative ecofriendly product-treatment offerings (https://ibn.fm/XGHjr). The patent was granted by the Israeli Patent Office for SVFD’s new-generation natural disinfecting composition and method to protect edible…

TuesdayJul 27, 2021 9:00 am

Carbon-free Ammonia Tech Developer FuelPositive Corp. (TSX.V: NHHH) (OTCQB: NHHHF) Boosts Investor Access with OTCQB Venture Trading, Cooperative Government Strategy

Canadian-based clean energy solutions innovator FuelPositive Corp. began trading on the OTCQB Venture Marketplace July 21 to increase its North American presence among investors The company will also continue trading on the TSX Venture Exchange in Canada FuelPositive’s primary IP strategy is to develop scalable and easily transportable commercial ammonia production units that are non-polluting and able to help the carbon-intense ammonia industry evolve The company is also increasing its ability to work with the Canadian government on mutual goals by hiring Sussex Strategy Group to provide government relations services The potential applications of FuelPositive’s technology extend beyond the agriculture…

MondayJul 26, 2021 3:53 pm

QualityStocksNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Secures $3.8M Through Warrant Exercises

Lexaria Bioscience Corp. (NASDAQ: LEXX, LEXXW), a global innovator in drug delivery platforms, today announced its receipt of US$3,817,643 from the exercise of share purchase warrants. According to the update, the company issued the warrants pursuant to its January 2021 public underwritten offering. The shares and warrants issued thereunder were registered pursuant to a Form S-1 Registration Statement (No. 333-250326), as amended, and a Form S-1MEF Registration Statement (No. 333-252031). The warrants were exercised into 580,189 shares of voting common stock of the company, each at an exercise price of US$6.58. The company will utilize all proceeds received from the…

MondayJul 26, 2021 2:54 pm

QualityStocksNewsBreaks – Sidoti & Company LLC Chooses IBN, IW for August Virtual Microcap Conference Communications Coverage

Sidoti is collaborating with InvestorBrandNetwork (“IBN”) and InvestorWire (“IW”) to provide coverage for its Sidoti August Virtual Microcap Conference. The prestigious two-day event, which will be presented in a digital format, is slated for Aug. 18-19, 2021. The conference offers a carefully vetted list of some 45 companies from a variety of different industries, including technology, telecommunication services, consumer discretionary, clean energy, industrials and more. Each company will have an opportunity to present a corporate overview as well as meet with sector-focused investors. A highly respected independent securities research firm, Sidoti has offered well-regarded small and microcap corporate conferences for the past 20 years. The firm…

MondayJul 26, 2021 1:20 pm

QualityStocksNewsBreaks – Tryp Therapeutics Inc. (CSE: TRYP) (OTCQB: TRYPF) Announces Strategic Board Appointments

Tryp Therapeutics (CSE: TRYP) (OTCQB: TRYPF), a pharmaceutical company focused on developing psilocybin-based compounds for diseases with unmet medical needs through accelerated regulatory pathways, today announced the appointment of Robin Carhart-Harris, Ph.D. as chairman of Tryp’s Scientific Advisory Board (“SAB”) and Daniel Clauw, M.D. as a new member of the SAB. Dr. Carhart-Harris initially joined Tryp’s SAB in February 2021 and has been instrumental in advising the company through the development of its Psilocybin-for-Neuropsychiatric Disorders (“PFN(TM)”) program. Dr. Clauw is a world-leading expert in fibromyalgia and other nociplastic pain indications. “With today’s announcement, I would like to thank Dr. Robin…

Site Search

Company Search

QualityStocksNewsBreaks – Green Hygienics Holdings Inc. (GRYN) Names New Senior VP of Global Sales and Business Development

QualityStocksNewsBreaks – Grapefruit USA Inc. (GPFT) Shares Insta Message from ELove: ‘Best Thing on the Market’

Flora Growth Corp. (NASDAQ: FLGC) Is ‘One to Watch’

The Alkaline Water Company Inc. (NASDAQ: WTER) (CSE: WTER) Finalizes Distribution Agreement with Largest Food Retailer in the Mid-Atlantic

Lexaria Bioscience Corp. (NASDAQ: LEXX) Completes VIRAL-A20-3 Pharmacokinetic Study on DehydraTECH(TM) Enabled Colchicine

Save Foods Inc. (NASDAQ: SVFD) Receives Seventh Global Patent for Proprietary Composition Method

Carbon-free Ammonia Tech Developer FuelPositive Corp. (TSX.V: NHHH) (OTCQB: NHHHF) Boosts Investor Access with OTCQB Venture Trading, Cooperative Government Strategy

QualityStocksNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Secures $3.8M Through Warrant Exercises

QualityStocksNewsBreaks – Sidoti & Company LLC Chooses IBN, IW for August Virtual Microcap Conference Communications Coverage

QualityStocksNewsBreaks – Tryp Therapeutics Inc. (CSE: TRYP) (OTCQB: TRYPF) Announces Strategic Board Appointments

Market Basics

Newsletter Publishers

Public Companies